ETF Components for AGNG - Global X Aging Population ETF


Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

Holdings

Symbol Grade Price % Change Allocation
WELL A 0.15 4.21
BSX A 1.39 3.60
BMY B 0.44 3.37
SYK A 0.76 3.13
AMGN D 0.03 3.10
MDT D 0.87 2.96
LLY F -1.07 2.93
JNJ D 1.06 2.89
ABBV F 2.01 2.86
AZN F 0.75 2.65
REGN F 0.41 2.40
VTR B 0.52 2.18
EW C 0.66 2.04
ZBH C -0.48 1.90
BGNE D 0.42 1.58
PODD B -0.70 1.56
UTHR C 0.96 1.55
DXCM C 0.44 1.51
INCY C -0.23 1.49
DVA C 1.23 1.15
NBIX C 1.57 1.04
EXEL B 0.10 0.90
OHI C 0.90 0.83
EXAS D 1.63 0.79
TFX F 1.64 0.76
ENSG D 1.11 0.70
GKOS A 1.68 0.58
HALO F -0.85 0.58
AGIO C 1.14 0.51
BPMC C 2.49 0.50
MMSI A 0.83 0.50
MNKD B -0.15 0.46
DNLI D -1.80 0.42
NHC C 1.77 0.40
ITGR B 1.65 0.38
EMBC C 1.84 0.38
NHI D 0.11 0.37
SBRA B -0.46 0.37
NVCR C -1.33 0.33
LTC B 0.81 0.33
TBPH B -1.71 0.30
AMED F 0.00 0.28
LIVN D -0.58 0.27
ACAD C -0.49 0.27
ALEC F 2.34 0.22
BKD F 0.67 0.22
ATEC C -0.76 0.18
AGL F 3.59 0.09

Recent News for Global X Aging Population ETF & its Holdings

Date Stock Title
Nov 21 MDT Here's Why Medtronic (MDT) is a Strong Value Stock
Nov 21 AZN We Think AstraZeneca's (LON:AZN) Healthy Earnings Might Be Conservative
Nov 21 NVCR Novocure Data at 2024 SNO Annual Meeting Highlights Product Innovation and Real-World Evidence for Tumor Treating Fields (TTFields) Therapy in Glioblastoma
Nov 21 NVCR FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma
Nov 21 MDT 3 Dividend Stocks I'll Never Sell
Nov 21 AMGN Analysis-Wall Street awaits Amgen weight-loss drug data expected to move shares
Nov 21 MDT Medtronic’s insulin pen app gains FDA clearance
Nov 21 LLY Eli Lilly, Verge announce milestones in ALS collaboration
Nov 21 AZN 3 Growth Stocks Trading Near Their 52-Week Lows to Buy Right Now
Nov 21 AMGN Amgen picks prolific biotech founder Chang as new top scientist
Nov 21 AZN AstraZeneca upgraded to Neutral from Sell at UBS
Nov 21 AZN AstraZeneca price target lowered to EUR 140 from EUR 150 at Berenberg
Nov 21 LLY Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop
Nov 21 AMGN Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop
Nov 20 PODD Insulet Corporation: Significant Opportunities, Significant Threats - I'm On The Sidelines
Nov 20 LLY Jim Cramer on Eli Lilly and Company (LLY): ‘I’m Kind Of Blown Away’
Nov 20 VTR Ventas Earns Nareit 2024 Healthcare "Leader in the Light" Award
Nov 20 AMGN AMGEN ANNOUNCES SENIOR EXECUTIVE RESEARCH APPOINTMENT
Nov 20 MDT Medtronic plc (MDT): A Key Player in Ken Griffin’s Portfolio with Steady Growth
Nov 20 JNJ Update: Market Chatter: Johnson & Johnson, Merck Cut Jobs in China
The investment seeks results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Global Longevity Thematic Index. The fund invests more than 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies in developed markets that facilitate the demographic trend of longer average life spans and the aging of the global population, including but not limited to companies involved in biotechnology, medical devices, pharmaceuticals, senior living facilities and specialized health care services.
Biotechnology Structured Finance Pharmaceutical Financial Market Health Care Services
Back to the Main AGNG Page...